FGFR3 and urinary bladder cancer: In a tobacco carcinogen OH-BBN-induced mouse bladder cancer model, the FGFR3-S249C mutation led to enhanced bladder tumorigenesis but also suppressed the acute inflammatory response at an early tumor initiation stage [92].